4 results match your criteria: "Centre National de la RechercheScientifique[Affiliation]"

The authors wish to point out that the name of the first author is appearing incorrectly on Pubmed: it should be El Ghouzzi V (and not Ghouzzi VE). In addition, the words "and p53" appear at the end of the title in the original publication ( https://www.nature.

View Article and Find Full Text PDF

Epidemiological evidence from the current outbreak of Zika virus (ZIKV) and recent studies in animal models indicate a strong causal link between ZIKV and microcephaly. ZIKV infection induces cell-cycle arrest and apoptosis in proliferating neural progenitors. However, the mechanisms leading to these phenotypes are still largely obscure.

View Article and Find Full Text PDF

MR-guided adaptive focusing of ultrasound.

IEEE Trans Ultrason Ferroelectr Freq Control

August 2010

Institut Langevin, Ecole Superieure de Physiqueet de Chimie Industrielles ParisTech, Centre National de la RechercheScientifique UMR 7587, Institut National de la Sante et de la Recherche Medicale U979, Universite Paris VII, Laboratoire Ondes et Acoustique, Paris, France.

Adaptive focusing of ultrasonic waves under the guidance of a magnetic resonance (MR) system is demonstrated for medical applications. This technique is based on the maximization of the ultrasonic wave intensity at one targeted point in space. The wave intensity is indirectly estimated from the local tissue displacement induced at the chosen focus by the acoustic radiation force of ultrasonic beams.

View Article and Find Full Text PDF

Multiple endocrine neoplasia type 2 (MEN 2) is a dominantly inherited cancer syndrome that comprises three clinical subtypes: MEN type 2A (MEN-2A), MEN type 2B (MEN-2B), and familial medullary thyroid carcinoma (FMTC). Medullary thyroid carcinoma (MTC), a malignant tumor arising from calcitonin-secreting thyroid C cells, is the cardinal disease feature of this syndrome, and mortality in affected MEN-2 patients is mainly caused by this malignancy. Germ-line mutations of the RET protooncogene, which encodes a receptor tyrosine kinase, are responsible for these three neoplastic-prone disorders.

View Article and Find Full Text PDF